;
Author Verified
RCT
Published: Mar 2007
ACE Report #5101
Ace Report Cover Tumour

Osteosarcoma: methotrexate & doxorubicin versus methotrexate, etoposide & ifosfamide


Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A

SFOP OS94: a randomised trial comparing preoperative high-dose methotrexate plus doxorubicin to high-dose methotrexate plus etoposide and ifosfamide in osteosarcoma patients

Eur J Cancer. 2007 Mar;43(4):752-61. Epub 2007 Jan 30

Contributing Authors: MC Le Deley JM Guinebretiere JC Gentet H Pacquement F Pichon P Marec-Berard N Entz-Werle C Schmitt L Brugieres D Vanel N Dupouy MD Tabone C Kalifa (SFOP) Societe Francaise d'Oncologie Pediatrique

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.

LEARN MORE

Please Login or Join to leave comments.